Longterm survival after pancreaticoduodenectomy for periampullary adenocarcinomas

HPB

Volumn 15, Issue 12, 2013, Pages 951-957

  Chen, Shih Chin ^a   Shyr, Yi Ming ^a   Wang, Shin E ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL ABSCESS; ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER SURGERY; CANCER SURVIVAL; CANCER SURVIVOR; CELL DIFFERENTIATION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GENDER; HUMAN; JAUNDICE; LONG TERM SURVIVAL; LYMPH NODE; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; PANCREATICODUODENECTOMY; PERIAMPULLARY ADENOCARCINOMA; PERINEURAL INVASION; POSTOPERATIVE HEMORRHAGE; PRIMARY TUMOR; SURGICAL MORTALITY; SURVIVAL RATE; SURVIVAL TIME; VATER PAPILLA CARCINOMA; WOUND INFECTION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; AMPULLA OF VATER; COMMON BILE DUCT NEOPLASMS; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; RISK FACTORS; SURVIVORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84887319239     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/hpb.12071     Document Type: Article

References (36)

1. Bottger TC, Junginger T,. (1999) Factors influencing morbidity and mortality after pancreaticoduodenectomy: critical analysis of 221 resections. World J Surg 23: 164-172.
2. Trede M, Schwall G, Saeger HD,. (1990) Survival after pancreaticoduodenectomy: 118 consecutive resections without an operative mortality. Ann Surg 990: 447-458.
3. Cameron JL, Pitt HA, Yeo CJ, Lillemoe KD, Kaufman HS, Coleman J,. (1993) One hundred and forty-five consecutive pancreaticoduodenectomies without mortality. Ann Surg 217: 430-438.
4. Castillo CFD, Rattner DW, Warshaw AL,. (1995) Standards for pancreatic resection in the 1990s. Arch Surg 130: 295-300.
5. Yeo CJ, Cameron JL, Sohn TA, Lillemoe KD, Pitt HA, Talamini MA, et al. (1997) Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s, pathology, complications, and outcomes. Ann Surg 226: 248-260.
6. Cleary SP, Gryfe R, Guindi M, Greig P, Smith L, Mackenzie R, et al. (2004) Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors. J Am Coll Surg 198: 722-731.
7. Jamieson NB, Foulis AK, Oien KA, Going JJ, Glen P, Dickson EJ, et al. (2010) Positive mobilization margins alone do not influence survival following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma. Ann Surg 251: 1003-1010.
8. Riall TS, Cameron JL, Lillemoe KD, Winter JM, Campbell KA, Hruban RH,. (2006) Resected periampullary adenocarcinoma: 5-year survivors and their 6- to 10-year follow-up. Surgery 140: 764-772.
9. Schnelldorfer T, Ware AL, Sarr MG, Smyrk TC, Zhang L, Qin R, et al. (2008) Longterm survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible? Ann Surg 247: 456-462.
10. Adham M, Jaeck D, Le Borgne J, Oussoultzouglou E, Chenard-Neu MP, Mosnier JF, et al. (2008) Longterm survival (5-20 years) after pancreatectomy for pancreatic ductal adenocarcinoma: a series of 30 patients collected from three institutions. Pancreas 37: 352-357.
11. Han SS, Jang JY, Kim SW, Kim WH, Lee KU, Park YH,. (2006) Analysis of longterm survivors after surgical resection for pancreatic cancer. Pancreas 32: 271-275.
12. Allison DC, Piantadosi S, Hruban RH, Dooley WC, Fishman EK, Yeo CJ, et al. (1998) DNA content and other factors associated with 10-year survival after resection of pancreatic carcinoma. J Surg Oncol 67: 151-159.
13. Katz MH, Wang H, Fleming JB, Sun CC, Hwang RF, Wolff RA, et al. (2009) Longterm survival after multidisciplinary management of resected pancreatic adenocarcinoma. Ann Surg Oncol 16: 836-847.
14. Howard TJ, Krug JE, Yu J, Zyromski NJ, Schmidt CM, Jacobson LE, et al. (2006) A margin-negative R0 resection accomplished with minimal postoperative complications is the surgeon's contribution to longterm survival in pancreatic cancer. J Gastrointest Surg 10: 1338-1345.
15. Richter A, Niedergethmann M, Sturm JW, Lorenz D, Post S, Trede M,. (2003) Longterm results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience. World J Surg 27: 324-329.
16. Mosca F, Giulianotti PC, Balestracci T, Di Candio G, Pietrabissa A, Sbrana F, et al. (1997) Longterm survival in pancreatic cancer: pylorus-preserving versus Whipple pancreatoduodenectomy. Surgery 122: 553-566.
17. Kuhlmann KF, de Castro SM, Wesseling JG, ten Kate FJ, Offerhaus GJ, Busch OR, et al. (2004) Surgical treatment of pancreatic adenocarcinoma; actual survival and prognostic factors in 343 patients. Eur J Cancer 40: 549-558.
18. Geer RJ, Brennan MF,. (1993) Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg 165: 68-73.
19. Sener SF, Fremgen A, Menck HR, Winchester DP,. (1999) Pancreatic cancer: a report of treatment and survival trends from 100,313 patients diagnosed from 1985-1995, using the national cancer database. J Am Coll Surg 189: 1-7.
20. Yeo CJ, Cameron JL, Lillemoe KD, Sitzmann JV, Hruban RH, Goodman SN, et al. (1995) Pancreaticoduodenectomy for cancer of the head of the pancreas: 201 patients. Ann Surg 221: 721-733.
21. Yeo CJ, Sohn TA, Cameron JL, Hruban RH, Lillemoe KD, Pitt HA,. (1998) Periampullary adenocarcinoma, analysis of 5-year survivors. Ann Surg 227: 821-831.
22. Burris HA 3rd, Moore MJ, Andersen J, Green MR, Rothenberg ML, Modiano MR, et al. (1997) Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreatic cancer: a randomized trial. J Clin Oncol 15: 2403-2413.
23. Neoptolemos JP, Stocken DD, Friess H, Bassi C, Dunn JA, Hickey H, et al. (2004) A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 350: 1200-1210.
24. Ahmad NA, Lewis JD, Ginsberg GG, Haller DG, Morris JB, Williams NN, et al. (2001) Longterm survival after pancreatic resection for pancreatic adenocarcinoma. Am J Gastroenterol 96: 2609-2615.
25. Zacharias T, Jaeck D, Oussoultzoglou E, Neuville A, Bachellier P,. (2007) Impact of lymph node involvement on longterm survival after R0 pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas. J Gastrointest Surg 11: 350-356.
26. Schäfer M, Mullhaupt B, Clavien PA,. (2002) Evidence-based pancreatic head resection for pancreatic cancer and chronic pancreatitis. Ann Surg 236: 137-148.
27. Kure S, Kaneko T, Takeda S, Inoue S, Nakao A,. (2005) Analysis of longterm survivors after surgical resection for invasive pancreatic cancer. HPB Surg 7: 129-134.
28. Pawlik TM, Gleisner AL, Cameron JL, Winter JM, Assumpcao L, Lillemoe KD, et al. (2007) Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer. Surgery 141: 610-618.
29. Gudjonsson B,. (1987) Cancer of the pancreas: 50 years of surgery. Cancer 60: 2284-2303.
30. Edge SB, Schmeig RE, Rosenlof LK, Wilhelm MC,. (1993) Pancreas cancer resection outcome in American university centres in 1989-1990. Cancer 71: 3502-3507.
31. Talamini MA, Moesinger RC, Pitt HA, Sohn TA, Hruban RH, Lillemoe KD, et al. (1997) Adenocarcinoma of the ampulla of Vater: a 28-year experience. Ann Surg 225: 590-600.
32. Monson JR, Donohue JH, McEntee GP, McIlrath DC, van, Heerden JA, Shorter RG, et al. (1991) Radical resection for carcinoma of the ampulla of Vater. Arch Surg 126: 353-357.
33. Matory YL, Gaynor J, Brennan M,. (1993) Carcinoma of the ampulla of Vater. Surg Gynecol Obstet 177: 366-370.
34. Sohn TA, Lillemoe KD, Cameron JL, Pitt HA, Kaufman HS, Hruban RH, et al. (1998) Adenocarcinoma of the duodenum: factors influencing longterm survival. J Gastrointest Surg 2: 79-87.
35. Bakaeen FG, Murr MM, Sarr MG, Thompson GB, Farnell MB, Nagorney DM, et al. (2000) What prognostic factors are important in duodenal adenocarcinoma? Arch Surg 135: 635-641.
36. Nakeeb A, Pitt HA, Sohn TA, Coleman J, Abrams RA, Piantadosi S, et al. (1996) Cholangiocarcinoma: a spectrum of intrahepatic, perihilar, and distal tumours. Ann Surg 224: 463-475.